Tuberculosis-Related Outcomes in Dermatologic Patients Receiving Systemic Therapy

Дата публикации: 01-09-2026 00:00:00

This systematic review and meta-analysis evaluates the incidence of active tuberculosis and latent tuberculosis infection conversion in dermatologic patients receiving systemic therapy.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation	0	8.17	01-09-2026
2	Patient Engagement With Dermatology Notes in the Electronic Patient Portal	0	9.2	01-09-2026
3	Golimumab in Treatment-Refractory Hidradenitis Suppurativa	0	7.71	01-09-2026
4	Postural Orthostatic Tachycardia Syndrome and Dermatomyositis	0	9.48	01-09-2026
5	Improved Risk Stratification in Mycosis Fungoides and Sézary Syndrome	0	8.93	07-10-2026
6	Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma	0	6.29	01-09-2026
7	CLIPI and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome	0	8.48	07-10-2026
8	BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus	0	28.92	30-09-2026
9	Lumpectomy Margins and Local Recurrence in DCIS	0	8.55	01-09-2026
10	Efficacy of Technology-Augmented Behavioral Counseling for Risky Firearm Behaviors	0	10.37	28-09-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10.27. Источник: archderm.jamanetwork.com.